Your session is about to expire
← Back to Search
Neural and Hormonal Influences on Alcohol Use Disorder Risk
Study Summary
This trial is looking at the neural and hormonal factors that contribute to why women are more at risk for AUD than men. They will be looking at three addiction domains: inhibitory control (executive function), negative emotionality, and alcohol cue reactivity (incentive salience).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 2 trial • 17 Patients • NCT01779024Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have regular menstrual cycles.I take medication that shouldn't be mixed with alcohol due to my health condition.My weight is either below 110 lbs or above 210 lbs.You drink around 4 to 5 alcoholic drinks every week.I am not pregnant, nursing, or using hormonal birth control.You have certain conditions that make it unsafe for you to have an fMRI scan.You prefer to use your right hand for tasks.You have significant health issues that need to be treated by a doctor.You have a problem with using drugs other than alcohol.You smoke more than 5 cigarettes per day.
- Group 1: Males
- Group 2: Females
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom is eligibility for participation in this trial extended?
"This medical experiment is actively recruiting 100 individuals with a drinking habit aged between 21 and 26. To be eligible, candidates must down 4/5 drinks per week on average."
Are there any openings remaining for participation in this experiment?
"As confirmed by clinicaltrials.gov, this medical trial is still seeking participants who meet the inclusion criteria. The initial posting of the study occurred on May 11th 2021 and was updated as recently as October 20th 2022."
In what types of ailments is alcohol typically prescribed?
"Obstructive hypertrophic cardiomyopathy is traditionally treated with Alcohol, although this treatment modality can be utilized to manage communicable diseases, ethylene glycol poisoning, and skin disinfection therapy."
Is this trial open to geriatric individuals?
"To be eligible to join this trial, patients must lie within the 21-26 year age bracket. Alternatively, there are 40 experiments available for those under 18 and 262 studies open to participants older than 65 years old."
How many participants are involved in this investigation?
"That is correct. In accordance with the information on clinicaltrials.gov, this medical study has been actively recruiting since its initial posting date of May 11th 2021 and was last edited on October 20th 2022. The trial seeks to enrol 100 patients from a single site."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger